210
Views
4
CrossRef citations to date
0
Altmetric
Review

Fixed-combination topical anti-hypertensive ophthalmic agents

, ORCID Icon &
Pages 1269-1282 | Received 24 Nov 2019, Accepted 12 Mar 2020, Published online: 31 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wesam Shamseldin Shalaby, Vikram Shankar, Reza Razeghinejad & L. Jay Katz. (2020) Current and new pharmacotherapeutic approaches for glaucoma. Expert Opinion on Pharmacotherapy 21:16, pages 2027-2040.
Read now

Articles from other publishers (3)

Tao Wang, Yunran Zhang, Meiling Chi, Chen Zhao, Linlin Cao, Chutong Tian, K. Kamei, Ying Zheng & Qikun Jiang. (2022) A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension. Asian Journal of Pharmaceutical Sciences 17:6, pages 938-948.
Crossref
Jingchao Yan, Xiaomei Xiong, Jianwen Shen & Taomin Huang. (2021) The use of fixed dose drug combinations for glaucoma in clinical settings: a retrospective, observational, single-centre study. International Ophthalmology 42:3, pages 945-950.
Crossref
Mayara Rodrigues Brandão de Paiva, Raquel Gregório Arribada, Carolina Nunes da Silva, Marcela Coelho Silva Ribeiro, Rodrigo Jorge, Silvia Ligório Fialho & Armando Silva-Cunha. (2020) Assessment of the safety of intravitreal injection of metoprolol tartrate in rabbits. Documenta Ophthalmologica 142:1, pages 75-85.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.